Calpain-mediated tau cleavage: A mechanism leading to neurodegeneration shared by multiple tauopathies

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 676-685

  Ferreira, Adriana ^a   Bigio, Eileen H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC CONSERVATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TAUOPATHY; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; CALPAIN; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MOLECULAR WEIGHT; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; PRIMARY CELL CULTURE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAU PROTEINS; TAUOPATHIES;

EID: 79960735446     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00220     Document Type: Article

References (65)

1. Yancopoulou D, Spillantini MG. (2003) Tau protein in familial and sporadic diseases. Neuromol. Med. 4:37-48.
2. Gotz J. (2001) Tau and transgenic animal models. Brain. Res. Rev. 35:266-86.
3. Lee VM, Goedert M, Trojanowski JQ. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24:1121-59.
4. Gamblin TC, et al. (2003a) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 100:10032-37.
5. Guo H, et al. (2004) Active caspase-6 and caspase-6 cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165:523-31.
6. Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry RW, Binder LI. (2006) N-terminal fragments of tau inhibit full-length tau polymerization in vitro. Biochem. 45:12859-66.
7. Reynolds MR, Berry RW, Binder LI. (2005) Sitespecific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease. Biochem. 44:1690-00.
8. Reynolds MR, Lukas TJ, Berry RW, Binder LI. (2006) Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms. Biochem. 45:4314-26.
9. Park SY, Ferreira A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J. Neurosci. 25:5365-75.
10. Park SY, Tournell C, Sinjoanu RC, Ferreira A. (2007) Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons. Neurosci. 144:119-27.
11. Sinjoanu RC, et al. (2008) The novel calpain inhibitor A-705253 potently inhibits oligomeric betaamyloid- induced dynamin 1 and tau cleavage in hippocampal neurons. Neurochem. Intl. 53:79-88.
12. Adamec E, Mohan P, Vonsattel JP, Nixon RA. (2002) Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta. Neuropathol. 104:92-104.
13. Albers DS, Beal MF. (2002) Mitochondrial dysfunction in progressive supranuclear palsy. Neurochem. Int. 40:559-64.
14. LaFerla FM. (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat. Rev. Neurosci. 3:862-72.
15. Furokawa K, et al. (2003) Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J. Neurochem. 87:427-36.
16. Xie CW. (2004) Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic dysfunction. Neuromol. Med. 6:53-64.
17. Braak H, Braak E. (1991) Neuropathological staging of Alzheimer-related changes. Acta. Neuropathol. 82:239-59.
18. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-85.
19. Goslin K, Banker GA. (1991) Rat hippocampal neurons in low-density culture. In: Culturing Nerve Cells. Banker G, Goslin K (eds). MIT Press, Cambridge, pp. 251-83.
20. Ferreira A, Lu Q, Orecchio L, Kosik KS. (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol. Cell. Neurosci. 9:220-34.
21. Bottenstein JE, Sato GH. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U. S. A. 76:514-17.
22. Rapoport M, Ferreira A. (2000) PD98059 prevents neurite degeneration induced by fibrillar beta amyloid in mature hippocampal neurons. J. Neurochem. 74:125-33.
23. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. (2002) Tau is essential to beta-amyloidinduced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 99:6364-69.
24. Towbin H, Staehelin T, Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350-54.
25. Yakunin AF, Hallenbeck PC. (1998) A luminol/ iodophenol chemiluminescent detection system for Western immunoblots. Anal. Biochem. 258:146-49.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-75.
27. Bensadoun A, Weinstein D. (1976) Assay of proteins in the presence of interfering materials. Anal. Biochem. 70:241-50.
28. Carlson SW, et al. (2007) A complex mechanism for inducer mediated tau polymerization. Biochem. 46:8838-49.
29. Chirita CN, Congdon EE, Yin H, Kuret J. (2005) Triggers of full-length tau aggregation: a role for partially folded intermediates. Biochem. 44:5862-72.
30. Gamblin TC, Berry RW, Binder LI. (2003b) Tau polymerization: role of the amino terminus. Biochem. 42:2252-57.
31. Kelly B, Ferreira A. (2006) Beta-amyloid-induced dynamin 1 degradation is mediated by NMDA receptors in hippocampal neurons. J. Biol. Chem. 281:28079-89.
32. Czogalla A, Sikorski AF. (2005) Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell. Mol. Life Sci. 62:1913-24.
33. King ME, Ahuja V, Binder LI, Kuret J. (1999) Ligand- dependent tau filament formation: implications for Alzheimer's disease progression. Biochem. 38:14851-59.
34. LeVine H. (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:274-84.
35. Santa-Maria I, Perez M, Hernandez F, Avila J, Moreno FJ. (2006) Characteristics of the binding of thioflavin S to tau paired helical filaments. J. Alz. Dis. 9:279-85.
36. Yang LS. Ksiezak-Reding H. (1995) Calpaininduced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233:9-17.
37. Yang LS, Gordon-Krajcer, W, Ksiezak-Reding H. (1997) Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain- mediated proteolysis. J. Neurochem. 69:1548-58.
38. Biernat J,.et al. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule-binding region. EMBO J. 11:1593-97.
39. Biernat J, Gustke N, Drewes G, Mandelkow E-M, Mandelkow E. (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11:153-63.
40. Bramblett GT, et al. (1993) Abnormal tau phosphorylation at Ser 396 in Alzheimer's disease recapitulates development and contributes to reduce microtubule binding. Neuron. 10:1089-99.
41. Brion JP, Smith C, Couck AM, Gallo JM, Anderton BH. (1993) Developmental changes in tau phosphorylation: foetal tau is transiently phosphorylated in a manner similar to paired helical filament tau characteristics of Alzheimer's disease. J. Neurochem. 61:2071-80.
42. Drewes G, et al. (1992) Mitogen-activated protein (MAP) kinase transforms tau protein into an Alzheimer- like state. EMBO J. 6:2131-38.
43. Drewes G, Ebneth A, Preusss U, Mandelkow E-M, Mandelkow E. (1997) MARK a novel family of protein kinases that phosphorylate microtubuleassociated proteins and trigger microtubule disruption. Cell. 89:297-08.
44. Goedert M, Spillatine, MG, Jakes R, Rutherford D, Crowther RA. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:519-26.
45. Goedert M, Cohen ES, Jakes R, Cohen P. (1992) p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease. FEBS Lett. 312:95-99.
46. Grunke-Iqbal I, et al. microtubule-associated protein t (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 83:4913-17.
47. Kosik KS, Joachim CL, Selkoe DJ. (1986) Microtubule- associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 83:4044-48.
48. Takashima A, Noguchi K, Sato K, Hoshimo T, Imahori K. (1993) Tau protein kinase I is essential for ß-protein induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 90:7789-93.
49. Bauman K, Mandelkow E-M, Biernat J, Piwnica- Worms H, Mandelkow E. (1993) Abnormal Alzheimer's like phosphorylation of tau protein by cyclin- dependent cdk2 and cdk5. FEBS Lett. 36:417-24.
50. Busciglio J, Lorenzo A, Yeh J, Yankner BA. (1995) ße-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:879-88.
51. Hanger DP, Hughes K, Woodgett, JR, Brion JP, Anderton BH. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147:58-62.
52. Mandelkow E-M, et al. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubuleassociated protein tau. FEBS Lett. 314:315-21.
53. Cho JH, Johnson GV. (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol. Chem. 279:54716-23.
54. Liu J, Liu MC, Kevin K, Wang W. (2008) Calpain in the CNS: from synaptic function to neurotoxicity. Sci. Signal. 1: re1 DOI 10.1126/stke.114re1.
55. Saito K-I, Elce JS, Hamos JE, Nixon RA. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain of Alzheimer's disease: A potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 90:2628-32.
56. Lee MS, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 405:360-64.
57. Law A, Gauthier S, Quirion R. (2001) Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br. J. Pharmacol. 133:1114-24.
58. Vaisid T, Kosower NS, Katzav A, Chapman J, Barnoy S. (2007) Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Neurochem. Intl. 51:391-97.
59. Glading A, et al. (2004) Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24:2499-2512.
60. Zadran S, Jourdi H, Rostamiani K, Qin Q, Bi X, Baudry M. (2010) Brain-derived neurotrophic factor and epidermal growth factor activated neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J. Neurosci. 30:1086-1095.
61. Zadran S, Bi X, Baudry M. (2010) Regulation of calpain-2 in neurons: Implications for synaptic plasticity. Mol. Neurobiol. 42:143-150.
62. Nicholson A, Riherd-Methner DN, Ferreira A (2011) Membrane cholesterol modulates betaamyloid- dependent tau cleavage by inducing changes in the membrane content and localization of NMDA receptors. J. Biol. Chem. 286:976-986.
63. Goll DE, Thompson VF, Li H, Wei W, Cong J. (2003) The calpain system. Physiol. Rev. 83:731-01.
64. Rao MV, et al. (2008) Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J. Neurosci. 28:12241-54.
65. Garg S, Timm T, Mandelkow E-M, Mandelkow E, Wang Y. (2011) Cleavage of tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment. Neurobiol. Aging. 32:1-14.